Goldman Sachs Group Inc.’s alternative investment arm has agreed to buy a majority stake in Dutch generic drugmaker Synthon from BC Partners.

Skeena Resources (TSX: SKE) (NYSE: SKE) has unlocked $195 million in funding for its 100%-owned Eskay Creek project in ...

BC Partners has agreed to sell its majority stake in Synthon to Goldman Sachs Alternatives. Synthon is an international pharmaceutical company, with a platform specialized in developing, manufacturing ...

VANCOUVER, BC / ACCESSWIRE / December 16, 2024 / Skeena Resources Limited (TSX:SKE) (NYSE:SKE) ("Skeena Gold and Silver", "Skeena" or the ...

Goldman Sachs Asset Management has agreed a more than €2bn deal to acquire drugmaker Synthon from BC Partners, according to people familiar with the matter, as it hopes to capitalise on demand for off ...

Goldman Sachs’ asset arm is in the process of acquiring the Dutch pharmaceutical company Synthon International for 2 billion ...

Private equity is taking over animal clinics to raise prices and close down practices where workers demand better wages.

BC Partners is nearing a deal to sell Dutch generic drugmaker Synthon International Holding BV to Goldman Sachs Asset ...

The Conservative Party of B.C. says government officials should have been more aggressive in scrutinizing the finances of ...

Squamish-based startup FireSwarm Solutions Inc. has secured the funding to further develop its autonomous drone technology ...

Where will growers go for supplies now that BC Growers Supply is closing following its operator, BC Fruit Trees, applying for ...

Fraser Health has launched a public awareness campaign encouraging pregnant people and people with syphilis symptoms to get ...